Searchable abstracts of presentations at key conferences in endocrinology

ea0014p296 | (1) | ECE2007

Thyroid nodules in the elderly: role of ultrasound (US) and ultrasound-guided fine-needle aspiration biopsy (US-FNAB)

Triggiani Vincenzo , Guastamacchia Edoardo , Resta Francesco , Sabba Carlo , Tafaro Emilio

The prevalence of thyroid nodules is increased in the elderly. The aim of this study was to evaluate the accuracy of US and US-FNAB in the diagnosis of thyroid cancer in a population of elderly subjects, all of whose thyroid nodules were subjected to US-FNAB, with no prior selection based on dimensions or echo-pattern. Over a three-year period, 276 consecutive patients (64 males and 212 [76.8%] females), aged 65 to 87 (mean 70±4.4), underwent US evaluation and US-FNAB of ...

ea0020p363 | Diabetes and Cardiovascular | ECE2009

Chemotherapy does not influence measures of glycaemic control in non-diabetic patients affected by acute leukaemia

Triggiani Vincenzo , Guastamacchia Edoardo , Liso Vincenzo , Specchia Giorgina , Resta Francesco , Sabba Carlo , Licchelli Brunella , Tafaro Emilio

Aim: Aim of the study was the evaluation of the effects of chemotherapy on insulin secretion and insulin sensitivity in patients affected by acute leukaemia.Materials and methods: Thirty-two non-diabetic patients (17 male, 15 female; age 51.1±17.4, range 16–76 years; BMI=25.1±3.7, range 18.4–32.8 kg/m2; 6=18% with a family history of diabetes mellitus) affected by acute leukaemia, 4 LLA (12.5%) and 28 LMA (87.5%), have been...

ea0090p61 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

The dual GIP/GLP-1 receptor co-agonist Tirzepatide vs GLP-1 receptor agonists as add-on to basal insulin in uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis

Lisco Giuseppe , De Tullio Anna , Disoteo Olga , De Geronimo Vincenzo , Piazzolla Giuseppina , De Pergola Giovanni , Angelo Giagulli Vito , Jirillo Emilio , Guastamacchia Edoardo , Sabba Carlo , Triggiani Vincenzo

Tirzepatide, a once-weekly dual co-agonist of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide 1 (GLP-1) receptors, has been demonstrated to improve glucose control and reduced body weight in different therapeutic approaches. With this rapid review and meta-analysis, we systematically reviewed the efficacy and safety of injectable incretin-based therapy added to basal insulin compared to basal insulin plus background treatments titrated rigorously t...